RAFFERTY ASSET MANAGEMENT, LLC – Vertex Pharmaceuticals Incorporated Transaction History
RAFFERTY ASSET MANAGEMENT, LLC portfolio value:
$17.81M
portfolio value
RAFFERTY ASSET MANAGEMENT, LLC quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +31.20% | 14.62K shares | 4.59M | $289.54 | 61.51K |
| Q2 2022 | share | Decrease | -19.75% | -11.53K shares | -2.03M | $281.79 | 46.88K |
| Q1 2022 | share | Increase | +7.32% | 3.98K shares | 3.29M | $260.97 | 58.41K |
| Q4 2021 | share | Increase | +15.41% | 7.27K shares | 3.39M | $222.45 | 54.43K |
| Q3 2021 | share | Increase | +20.48% | 8.01K shares | 662K | $181.39 | 47.16K |
| Q2 2021 | share | Increase | +4.09% | 1.53K shares | -189K | $201.63 | 39.14K |
| Q1 2021 | share | Increase | +50.31% | 12.58K shares | 2.16M | $214.89 | 37.60K |
| Q4 2020 | share | Decrease | -1.92% | -491 shares | -1.02M | $236.34 | 25.02K |
| Q3 2020 | share | Increase | +20.19% | 4.28K shares | 780K | $272.12 | 25.51K |
| Q2 2020 | share | Increase | +35.93% | 5.61K shares | 2.44M | $290.31 | 21.22K |
| Q1 2020 | share | Decrease | -58.04% | -21.6K shares | -4.43M | $237.95 | 15.61K |
| Q4 2019 | share | Decrease | -27.91% | -14.40K shares | -597K | $218.95 | 37.21K |
| Q3 2019 | share | Increase | +23.69% | 9.88K shares | 1.09M | $169.42 | 51.62K |
| Q2 2019 | share | Increase | +6.48% | 2.53K shares | 443K | $183.38 | 41.73K |
| Q1 2019 | share | Increase | +308.55% | 29.60K shares | 5.62M | $183.95 | 39.19K |
| Q4 2018 | share | Decrease | -13.10% | -1.44K shares | -538K | $165.71 | 9.59K |
| Q3 2018 | share | Increase | +0.43% | 47 shares | 260K | $192.74 | 11.04K |
| Q2 2018 | share | Increase | +19.05% | 1.75K shares | 363K | $169.96 | 10.99K |
| Q1 2018 | share | Decrease | -8.55% | -863 shares | -8K | $162.98 | 9.23K |
| Q4 2017 | share | Decrease | -32.68% | -4.90K shares | -767K | $149.86 | 10.09K |
| Q3 2017 | share | Decrease | -16.39% | -2.94K shares | -32K | $152.04 | 14.99K |
| Q2 2017 | share | Increase | +43.40% | 5.42K shares | 944K | $128.87 | 17.93K |
| Q1 2017 | share | Decrease | -4.58% | -601 shares | 402K | $109.35 | 12.50K |
| Q4 2016 | share | Increase | +65.59% | 5.19K shares | 276K | $73.67 | 13.11K |
| Q3 2016 | share | Increase | +16.82% | 1.14K shares | 107K | $87.21 | 7.91K |
| Q2 2016 | share | Decrease | -28.19% | -2.66K shares | -167K | $86.02 | 6.77K |
| Q1 2016 | share | Increase | +28.86% | 2.11K shares | -176K | $79.49 | 9.43K |